Warning lights
Signals from the annual accounts, the CBE and the Official Gazette, each with its threshold and source. No score, no verdict.
-
Tight liquidity NBB
Cash and receivables cover 16 % of short-term debt in 2025; threshold 65 %.
Financials
Financial year 2025
Société de Biologie Médicale et Moléculaire JM Gras from Namur, company number BE0607891872, closed financial year 2025 with a result of € 91,001 after tax. For that financial year Société de Biologie Médicale et Moléculaire JM Gras recorded a gross margin of € 137,871 and equity of € 22,184. Compared with financial year 2024, the result moved from € 69,554 to € 91,001. Profitable, and profit is growing. The buffer shrank hard: equity is 64 % below last year. Debts are under control. The most recent annual accounts were filed with the National Bank of Belgium on May 1, 2026.
€ 22,184
▼ 64% vs 2024
Assets minus debts, by the books. What is left if everything were sold and paid today.
€ 91,001
▲ 31% vs 2024
Profit after tax over the fiscal year.
€ 15,476
▼ 2% vs 2024
Cash and bank balances on the last day of the fiscal year.
€ 130,000 paid out
More than the year’s profit went to the shareholders; reserves fell.
People and assets in 2025
≈ 1
No payroll staff. One director, so that person most likely runs the business.
€ 52,932
▼ 27% vs 2024
Book value of vehicles, furniture and equipment.
Debts at end 2025
€ 30,277
▼ 33% vs 2024
€ 14,990 is repaid this year. At this pace the long-term loan is gone in ≈ 2 years.
€ 93
▼ 96% vs 2024
Supplier invoices still open on the last day of the fiscal year.
€ 1,016
▼ 42% vs 2024
Taxes, VAT and social contributions still to pay.
Want to see how much further we take a dossier in the Pro version? Open the free De Lijn example and give feedback →
| 2022 | 2023 | 2024 | 2025 | Change 2024 → 2025 | |
|---|---|---|---|---|---|
| Gross margin | € 61,378 | € 55,287 | € 108,778 | € 137,871 | ▲ 27% |
| Profit after taxes | € 42,866 | € 35,672 | € 69,554 | € 91,001 | ▲ 31% |
| Equity | € 51,957 | € 51,629 | € 61,183 | € 22,184 | ▼ 64% |
| Total debts | € 20,757 | € 102,295 | € 112,357 | € 124,190 | ▲ 11% |
| Cash | € 30,568 | € 24,762 | € 15,742 | € 15,476 | ▼ 2% |
| Retained profit | € 33,357 | € 33,029 | € 42,583 | € 3,584 | ▼ 92% |
| Dividend | € 12,000 | € 36,000 | € 60,000 | € 130,000 | ▲ 117% |
| Bank debt | € 0 | € 59,385 | € 44,975 | € 30,277 | ▼ 33% |
| Balance sheet total | € 72,714 | € 153,925 | € 173,540 | € 146,375 | ▼ 16% |
Key figures of Société de Biologie Médicale et Moléculaire JM Gras, fiscal years 2022 to 2025, from the annual accounts filed with the National Bank of Belgium.Next annual account (fiscal year 2026) expected before 31 July 2027.
What happened to Société de Biologie Médicale et Moléculaire JM Gras?
What happened at Société de Biologie Médicale et Moléculaire JM Gras in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:
- New annual accounts for financial year 2025: profit of € 91,001 (▲ 31% vs 2024). Source: NBB ↗
- New establishment in Namur. KBO
- Jérémie Gras became a director. NBB
- Start of the company according to the CBE. KBO
In short
From € 42,866 profit in 2022 to € 91,001 profit in 2025.
Paid € 68,587 in corporate taxes since 2022.
Best year ever: 2025, with € 91,001 profit.
Paid out € 238,000 in dividends to the owners in total.
A new publication or filing at Société de Biologie Médicale et Moléculaire JM Gras? We notify you, reason included.
Follow Société de Biologie Médicale et Moléculaire JM GrasDatabakkes Pro
Know what changes at your customers, suppliers and competitors. Without reading an annual account.
- Follow them in one folder Every company in your folder gets this full dossier: household book, all fiscal years, benchmark against companies of the same size.
- We alert you, with the reason New annual account, Official Gazette publication or status change: you get what changed and where it says so.
- In bulk too, and in ChatGPT and Claude Upload your customer list and get the warning signs back per company. Or ask in your own AI assistant, with this register as the source.
Databakkes Pro is being built. Sign up now and you are first in line for an invitation, with a month to try without a credit card.
De Lijn 8 June 2026 New annual account 2025
filed on 8 June 2026
What was left
€ 20 k ▼ 91%
Money in the bank
€ 178 k ▼ 98%
Open the dossier →
NMBS 8 June 2026 New annual account 2025 What was left ▼ 80%
bpost 18 May 2026 New annual account 2025 What was left from loss to profit
Management
Behind Société de Biologie Médicale et Moléculaire JM Gras is Jérémie Gras.
Directors
According to the 2025 annual accounts
Jérémie Gras
Director
since 2015
Establishments
Establishment units
Physical locations of this company
Rue des Verreries(JB) 114
5100 Namur
Rue Alexandre Colin(CH) 11 box 2B1
5020 Namur
Active since 20 March 2015
Who else lives here?
A building full of entrepreneurs or one very busy letterbox? Another 1 companies are registered at this address.
All companies at this address →What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.
Details
- Company number
- 0607.891.872
- VAT number
- BE 0607.891.872
- Registered office
- Rue des Verreries(JB) 114, 5100 Namur
- Names & denominations
- Société de Biologie Médicale et Moléculaire JM Gras · SBMM JM Gras
- Enterprise type
- Rechtspersoon
- Legal form
- Private limited company
- Legal situation
- Normale toestand
- Start date
- 20 March 2015
- Peppol
- Active · Active since 30 Nov 2025